Filter
642
Filtered Results: 642
Text search:
molecular
markers
Featured
Recommendations
82
New Publications
122
Language
Document type
No document type
262
Studies & Reports
139
Guidelines
138
Manuals
50
Strategic & Response Plan
26
Training Material
12
Fact sheets
10
Situation Updates
4
Resource Platforms
1
Countries / Regions
India
52
Global
29
Latin America and the Carribbean
18
Kenya
15
Tanzania
14
Western and Central Europe
12
Africa
11
Ethiopia
11
South Africa
9
Nigeria
8
Eastern Europe
8
South–East Asia Region
7
Uganda
7
Sierra Leone
5
Zimbabwe
5
Philippines
5
Asia
5
Ukraine
4
Malawi
4
West and Central Africa
4
Western Pacific Region
4
East and Southern Africa
4
Indonesia
4
Myanmar / Burma
4
Nepal
3
Ghana
3
Cameroon
3
Congo, Democratic Republic of
3
North America
3
Vietnam
3
Brazil
3
Pakistan
3
Thailand
2
Benin
2
China
2
Syria
2
Burkina Faso
2
Guinea
2
USA
2
Cambodia
2
Venezuela
2
Bangladesh
2
Namibia
2
Zambia
2
Liberia
2
North Macedonia
1
Timor Leste/ East Timor
1
Lesotho
1
Rwanda
1
Iran
1
Laos
1
Senegal
1
Afghanistan
1
Peru
1
Malaysia
1
Jordan
1
Germany
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Gabon
1
Japan
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Sri Lanka
1
Georgia
1
Angola
1
Chad
1
Somalia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
178
Clinical Guidelines
96
Public Health
43
Pharmacy & Technologies
25
Women & Child Health
16
Key Resources
16
Capacity Building
6
Toolboxes
TB
81
AMR
63
COVID-19
62
HIV
42
NTDs
37
Mental Health
34
Malaria
31
Planetary Health
23
NCDs
18
Rapid Response
15
Ebola & Marburg
14
Pharmacy
13
2.0 Rapid Response
11
Refugee
8
Specific Hazards
6
Zika
6
Global Health Education
6
Polio
5
Conflict
4
Disability
3
Cholera
3
Caregiver
3
Health Financing Toolbox
3
Natural Hazards
2
Social Ethics
1
The National Malaria Elimination Strategic Plan (NMESP) 2024–2028 of Ghana outlines the country’s roadmap to shift from malaria control to elimination. Despite major progress—like reducing malaria deaths from nearly 2,800 in 2012 to 151 in 2022—malaria remains a major public health challenge...
The National Strategic Plan on Malaria Prevention and Elimination Period 2021 – 2025 seeks to build on the previous national successes of the National Institute of Malariology, Parasitology, and Entomology (NIMPE) while addressing current challenges to reduce the overall burden of malaria in the S...
In line with the Defeating meningitis by 2030: a global road map, the WHO guidelines on meningitis diagnosis, treatment and care Executive Summary provides a summary of the evidence-based recommendations for the clinical management of children and adults with community-acquired meningitis, including...
The 2022 report reviews the global malaria diagnostics market and technological landscape to support Unitaid’s 2023–2027 strategy for quality malaria case management. The report highlights the stalled progress of malaria control efforts, the gaps in access to diagnostics and the public health im...
Action Plan 2021-2025
Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for rapidly progressive, potential fatal diseases including life-threatening pneumonia, necrotizing fascii...
Accessed Febr.6, 2020
The guidelines are to be used to guide the management of adults with lower respiratory tract infection (LRTI). As will be seen in the following text, this diagnosis, and the other clinical syndromes within this grouping, can be difficult to make accurately. In the absence of agreed definitions of th...
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination...
26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
The main purpose of the meeting was to review tsetse control tools, activities and their contribution to the elimination of gHAT and the monitoring thereof. Seven endemic countries provided reports on recent and ongoing vector control interventions at the national level (Angola, Cameroon, Côte d’...
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im...
A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
AHA/ASA Guideline
DOI: 10.1161/STR.0000000000000158
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen...
Research Article
Hindawi Publishing Corporation
AIDS Research and Treatment
Volume 2011, Article ID 621078, 7 pages doi:10.1155/2011/621078
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
SAGE-Hindawi Access to Research Autoimmune Diseases
Volume 2011, Article ID 937586, 5 pages doi:10.4061/2011/937586
This malaria case management training manual was developed by the Federal Ministry of Health (FMOH) of Ethiopia, in collaboration with several national and international partners. Primarily based on WHO guidelines and training materials, as well as the 2022 national malaria guidelines and various te...
